How A Former Goldman Sachs Banker Turns Her Autoimmune Condition Into A Modern Healthcare Business Centered Around Propolis

  • 📰 Forbes
  • ⏱ Reading Time:
  • 46 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 53%

United Kingdom News News

United Kingdom United Kingdom Latest News,United Kingdom United Kingdom Headlines

Challenged by a chronic autoimmune disorder growing up, Carly Stein-Kremer always knew it was her inner calling to provide more modern, efficacious food and supplements.

Beekeeper's Naturals

“I found propolis when I was in Europe, and it was the first time for me to solve my ongoing health challenges with it,” said Stein-Kremer, who later cofounded her entire business,, based on this resinous compound produced by bees and best known for fighting viruses, bacteria and supporting immunity.

This phenomenon, also known as colony collapse disorder, is also pushing a slew of food and beverage players to increasingly focus their missions on saving the bees and sourcing pesticides-free ingredients from regenerative farms, including New York City-based coffee shop Beepublic.

“I started to really focus on the integral role [bees] play in our ecosystem, and these more nuanced medicinal ingredients coming from the hive,” said Stein-Kremer, who also onboarded former attorney Daniel Millar as her cofounder, “and before I knew it, I had engineered a product line for myself.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in UK

United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Alibaba, other tech stocks drop as Goldman downgrades China growth forecastChina stocks had a rough ride on Monday, as Goldman Sachs piled on worries over growth and investors fretted the country won't move fast enough with stimulus.
Source: MarketWatch - 🏆 3. / 97 Read more »